Skip to content
Monday, November 9, 2026
HonestView

The Zimbabwean Government Rejects ‘Lopsided’ US Health Aid Agreement Because of Data Apprehensions

Medical funding image
The offered American funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

The nation of Zimbabwe has rejected a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over Washington's demand for confidential information.

The decision was revealed following a government memo from December was disclosed, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".

A government spokesperson later clarified that the United States was seeking health data for scientific study and commercial gain while was not willing to share the benefits from future treatments.

"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.

The US Embassy indicated the US had donated more than $1.9bn in health funding to Zimbabwe over the last two decades.

A physicians' group in Zimbabwe has called for continued negotiations to find a agreement agreeable to both sides so the nation's critical HIV programme can continue.

Broader Background

This rejection follows a similar case in Kenya, where a high court halted a similar health funding agreement after concerns were filed about the safety of citizens' health data.

After resuming office recently, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).

USAID had administered assistance for the US government, but Trump claimed its spending was "wasteful" and his government was seeking direct bilateral agreements to enhance transparency and responsibility.

According to statements, Sixteen African countries have so far signed these new agreements, constituting over $18.3bn of fresh investment.

Specifics of the Rejected Agreement

The money for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"We believe this collaboration might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently on antiretroviral therapy via American-funded initiatives," the Ambassador said.

However, official spokesman Nick Mangwana argued the arrangement was "unequal".

"Zimbabwe was being asked to provide its genetic material and health information indefinitely, with no equivalent assurance of access to any scientific breakthroughs – such as new medicines or tests – that could be developed from that shared data," he stated.

"Effectively, our country would provide the raw materials for medical research with no certainty that the end products would be accessible to our population if a new pandemic arise."

National Interest and Global Health

He also said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending structures previously established via the international organization.

Mangwana cited its Pandemic Benefit-Sharing scheme designed to deal with future global health emergencies.

"This system is intended to ensure that when a nation provides its samples, the benefits – including medicines and cures – are shared equitably, not commercialised exclusively by those with the funds to develop them."

The government's concerns over the US deal "are not meant as anti-American sentiment," he added.

"We welcome further dialogue with our US partners on how future co-operation could be designed in a way that respects the independence and interests of both nations."

Medical Community Reaction

A leading public health body stated it understood the official position, but recommended that negotiations must proceed since much of the country's HIV programmes relied on foreign aid.

"Where specific concerns exist, including those relating to information security or implementation frameworks, these can often be resolved through detailed discussion and negotiated safeguards," it commented.

The halted deal underscores the ongoing debate between receiving crucial international aid and protecting a country's data in an ever more interconnected world.

About the author

Dawn Morrison

Award-winning investigative journalist with over 15 years of experience covering international politics and media ethics.

HonestView

Type to search articles.